Trump signs executive order slashing prescription drug costs by up to 80%
- On Monday, Republican President Donald Trump signed a presidential directive aimed at reducing US prescription drug costs by aligning them with the lowest prices paid internationally.
- Trump launched this initiative to counter high domestic prices, blaming pharmaceutical companies and foreign governments for inflating costs paid by Americans.
- The plan hinges on drugmakers voluntarily reducing prices within 30 days, after which Health Secretary Robert F. Kennedy Jr. Must enact a rule tying US prices to lower foreign rates.
- Trump claimed drug prices should drop at least 59 percent, possibly up to 80 or 90 percent, while the pharmaceutical lobby called the order a bad deal threatening treatments and investments.
- Though Trump promised significant savings, experts say relief is unlikely soon, and the order could face legal challenges similar to previous efforts during his presidency.
643 Articles
643 Articles
Drug Price Executive Order Unleashes Unlikely Critics - Liberty Nation News
By John Klar President Donald Trump issued an executive order (EO) yesterday, May 12, designed to reduce drug prices for American patients and taxpayers alike. The move is a moderate effort to work amicably with pharmaceutical companies to cut taxpayer costs for Medicare and Medicaid, shave price gouging by middlemen, and usher in bipartisan “equity” for American consumers. […]
RFK Jr. to Newsmax: Trump Pharma Order Due to European Price-Fixing
Health and Human Services Secretary Robert F. Kennedy Jr. told Newsmax on Monday that the impetus behind President Donald Trump’s executive order to reduce prescription drug costs for Americans was price-fixing by European nations. Kennedy said Americans account for 75% of pharmaceutical company revenue but are just 4.2% of the world’s population. The result: Americans are paying more for prescription drugs than the rest of the world. “It’s not …
Decree: Trump blames "socialist health system in Germany" for high drug prices in the USA
The Americans would be excluded by the pharmaceutical companies because Europeans are capping drug prices, according to the US President. A decree is now to change this. At the same time, he wants to make drastic savings in health insurance for poorer citizens.
Coverage Details
Bias Distribution
- 49% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage